Ina A. Eilertsen

Nydalen, 0424, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines.

Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines.

Journal: Molecular biomedicine
Published: April 10, 2026

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.

Journal: Cell reports. Medicine
Published: December 11, 2025

Common gene mutations in 103 authenticated colorectal cancer cell lines.

Common gene mutations in 103 authenticated colorectal cancer cell lines.

Journal: Oncogenesis
Published: June 16, 2025

Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.

Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.

Journal: The British journal of surgery
Published: December 19, 2024

The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.

The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 12, 2024

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.

Journal: Nature communications
Published: August 23, 2023

Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.

Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.

Journal: EBioMedicine
Published: April 22, 2023

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.

Journal: NPJ genomic medicine
Published: January 15, 2021

The expressed mutational landscape of microsatellite stable colorectal cancers.

The expressed mutational landscape of microsatellite stable colorectal cancers.

Journal: Genome medicine
Published: January 06, 2021

De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.

De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.

Journal: Genome medicine
Published: December 14, 2020

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.

Journal: EBioMedicine
Published: February 11, 2020

Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.

Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 05, 2019
Showing 1-12 of 28

Last Updated: 09/26/2026